logo
Plus   Neg
Share
Email

Aegon Targets Reduce gross financial leverage; Implements EUR 400 Mln Expense Savings Program

Dutch life insurer Aegon NV (AGN.L,AEG) said it will target a reduction on its gross financial leverage to 5.0 billion euros - 5.5 billion euros by 2023 from 6.6 billion euros on June 30, 2020.

At Capital Markets Day, Aegon CEO Lard Friese said that the company is implementing an expense savings program aimed at reducing expenses by 400 million euros in 2023 compared with 2019, representing 13% of the addressable expense base.

Of the saving, 150 million euros will be reinvested in growth. Associated one-time investments are expected to be around 650 million euros over the period 2021 to 2023, and will be booked as Other charges.

The company expects total free cash flows to amount to 1.4 billion euros to 1.6 billion euros, cumulatively over the period 2021 to 2023.

The company aims to grow its dividend per share to around 0.25 euros over 2023.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The U.S. Food and Drug Administration is hastening its efforts to make available more at-home testing options in response to the ongoing COVID-19 pandemic. All At-Home Covid-19 Tests being used now are authorized only for emergency use, and not cleared or fully approved by the FDA. The recent granting of EUA for the Quidel Corp.'s QuickVue At-Home COVID-19 Test is one example. Dollar Tree Inc. (DLTR) Wednesday reported a profit for the fourth-quarter that climbed 309 percent from last year, while Wendy's Co. (WEN) posted a profit that grew about 46.0 percent from the prior year. Dollar Tree has increased its share repurchase authorization by $2.0 billion. Wendy's expects profit for fiscal year 2021 to be below analysts' expectations. Medical devices company Boston Scientific Corp. (BSX) agreed Wednesday to acquire the global surgical business of Israel-based Lumenis LTD from an affiliate of Baring Private Equity Asia (BPEA) for an upfront cash payment of $1.07 billion, subject to closing adjustments. Lumenis is a privately-held...
Follow RTT